Centiva Capital’s Celgene Corp CELG Stock Holding History

Centiva Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-59,035	Closed	-$5.86M	–	991
2019 Q3	$5.86M	Buy	59,035 +46,416	+368%	+$4.41M	0.36%	51
2019 Q2	$1.17M	Buy	12,619 +137	+1%	+$13K	0.07%	197
2019 Q1	$1.18M	Buy	12,482 +4,977	+66%	+$435K	0.08%	162
2018 Q4	$481K	Buy	+7,505	New	+$554K	0.04%	183

Other funds holding CELG

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Centiva Capital's CELG Position: Q4 2019 in Review

Centiva Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 59,035 shares — an estimated $5.86M sold.

Centiva Capital first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $5.86M in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Centiva Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Centiva Capital sold 59,035 Celgene Corp shares in Q4 2019, an estimated $5.86M.
Centiva Capital first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
Centiva Capital's Celgene Corp position peaked at $5.86M in Q3 2019.
3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Centiva Capital's 13F filing for Q4 2019, filed 14 Feb 2020.